Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-11-11

Clinical Trial Update: Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca [NA]

View source ↗

Summary

The trial investigating intravenous and intraperitoneal chemotherapy with abdominal hyperthermia for ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mark Dewhirst | Conditions: Ovarian Cancer | NA | Status: WITHDRAWN